|
Tuesday August 7, 2007
Hathaway (HWYI) Wholly Owned Subsidiary,
Diabetes Detection, Inc., Develops Medical Device to Detect Neuropathy
Deficiencies Currently Affecting Over 21 Million Americans and Millions
More Globally
Company Seeks to Gain FDA Approval Through Clinical Trials of the
Pager Unit Developed in Conjunction With Daviscomms (S), Ltd
PALO ALTO, CA--(MARKET WIRE)--Aug 7, 2007 -- Hathaway Corporation
(Other OTC:HWYI.PK - News), a company that focuses on acquiring,
developing, and managing disruptive technologies in the telecommunications,
medical devices and software fields, announced that their wholly
owned subsidiary DDI has, in conjunction with Daviscomms (S), Ltd,
announced the company has developed a pager with DDI's patent-pending
vibration technology and will utilize the pager to begin clinical
trials in testing diabetic patients for neuropathy deficiencies.
The pager unit is expected to be the first of several devices utilizing
the DDI vibrating technology to detect neuropathy in diabetic patients
here in the U.S. and other countries where this disease continues
to grow. Currently over 177 million people globally suffer from
diabetes and millions more have the potential to come down with
this disease in their lifetime unless properly diagnosed and treated.
"We have to give thanks to our internal management and the
engineers at Daviscomms (S) Ltd, for delivering this pager with
the DDI technology integrated into a unit that will allow us to
begin the process of clinical trials and subsequent FDA approval.
We have been working on several alliances that will assist DDI in
developing and managing the entire clinical trial process from start
to finish with the end target being FDA approval for the medical
device," stated Mr. Paul D. Lisenby, CEO of Hathaway.
About Daviscomm (S)
Daviscomm (S) is in the business of providing Contract Design and
Manufacturing services for a wide range of high quality consumer
and industrial wireless electronics products such as pagers and
paging systems, telemetry modules, and mobile handheld devices.
http://www.daviscomms.com.sg/index.htm
About Hathaway
Hathaway Global Inc. focuses on acquiring disruptive technologies
in the telecommunications, medical devices, and software fields
that can change or alter the way companies grow and service their
businesses. Hathaway provides financial and infrastructural support
to create revenue growth companies, positioning them to leverage
the opportunities such technologies are typically capable of. Hathaway
then offers the company on the public market or facilitates a buyout.
To request further information about Hathaway, please email us at
investors@hathawayglobal.com
Safe Harbor
This release includes forward-looking statements within the meaning
of Section 27A of the Securities Act of 1933 and Section 27E of
the Securities Act of 1934. Statements contained in this release
that are not historical facts may be deemed to be forward-looking
statements. Investors are cautioned that forward-looking statements
are inherently uncertain. Actual performance and results may differ
materially from that projected or suggested herein due to certain
risks and uncertainties including, without limitation, ability to
obtain financing and regulatory and shareholder approval for anticipated
actions.
Contact:
FutureTechIR for Hathaway Corporation
Investor Relations
(817) 812-2105 or
(727) 417-9338
|
